Keywords: medimmune, licenses, humab-mouse, tech, medarex, entered, into

MedImmune licenses HuMAb-Mouse tech from Medarex

Article | 15 June 2000

MedImmune has entered into an agreement with Medarex under which itwill use the latter's HuMAb-Mouse technology to develop fully-human antibodies ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Palivizumab

Synagis

Go to drug listing